StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19+0.00 (+1.30%)

Close on Nov 17, 2026Market cap $2.39MP/E –Yield –

20/20 Biolabs cash

Cash and short-term investments held at the end of each period.

20/20 Biolabs's cash was $4.55M at Jun 30, 2026. For fiscal 2025 it was $1.03M, down 42.5% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.03M-42.5%
FY2024Dec 31, 2024$1.78M-56.4%
FY2023Dec 31, 2023$4.09M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.55M+191.8%
Q1 FY2026Mar 31, 2026$4.22M+136.5%
Q4 FY2025Dec 31, 2025$1.03M-74.9%
Q2 FY2025Jun 30, 2025$1.02M–
Q1 FY2025Mar 31, 2025$1.56M–
Q4 FY2024Dec 31, 2024$1.78M–
Q4 FY2023Dec 31, 2023$4.09M–

More 20/20 Biolabs figures

See a number that looks wrong?